The reaction led to a withdrawal of that order and a reconsideration: The DEA is now giving the public until December 1 to send comments on whether or not the drug should be placed on Schedule 1
Some people believe certain sites cause fewer side effects, but reactions vary individually
the Judicial Panel on Multidistrict Litigation added Saxenda to MDL 3094 in December 2024, expanding the scope to include this earlier-generation GLP-1 medication The consolidation of these medications into a single MDL proceedings streamlines the litigation process while allowing each plaintiff to maintain their individual claim for damages
[DOI] [PubMed] [Google Scholar] 56.Chertow GM, Vart P, Jongs N, Toto RD, Gorriz JL, Hou FF, et al
Given the known side effects of GLP-1s such as intestinal discomfort and muscle loss, most people have trouble staying on them for more than a year and the weight loss is often reversed once they stop